DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
DaVita Inc. (NYSE: DVA) has announced its participation in the upcoming Barclays Global Healthcare Conference 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DaVita Inc. (NYSE: DVA) has announced its participation in the upcoming Barclays Global Healthcare Conference 2025. The company's CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will engage in a fireside chat with investors on March 11, 2025, at 9:00 a.m. EDT.
DaVita is a comprehensive kidney care provider with a 25-year track record in clinical quality and innovation. As of December 31, 2024, the company serves 281,100 patients across 3,166 outpatient dialysis centers, with 2,657 centers in the United States and 509 centers across 13 other countries. The company specializes in various aspects of kidney health, from disease progression management to transplantation support and home dialysis services.
Details
News Market Reaction – DVA
The recorded move for DVA in the trading session of this news was +0.26%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To view the live webcast, visit the Barclays page and create a free registration.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2024, DaVita served approximately 281,100 patients at 3,166 outpatient dialysis centers, of which 2,657 centers were located in the United States and 509 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-the-barclays-global-healthcare-conference-2025-302394668.html
SOURCE DaVita
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.